EGFR and HER2 Expression in Advanced Biliary Tract Cancer

Zeitschrift fur Gastroenterologie - Germany
doi 10.1055/s-0028-1089488
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Anti-Egfr Monoclonal Antibodies in Advanced Biliary Tract Cancer: A Systematic Review and Meta-Analysis

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2020English

Epidermal Growth Factor Receptor (EGFR) in Biliary Tract Cancer

HPB
HepatologyGastroenterology
2016English

Biweekly Cisplatin and Gemcitabine in Patients With Advanced Biliary Tract Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

Thromboembolic Events as Prognostic Clinical Markers in Advanced Pancreatic and Biliary Tract Cancer

The Korean Journal of Medicine
2018English

Irinotecan Plus Gemcitabine and Fluorouracil in Advanced Biliary Tract Cancer: A Retrospective Study

Digestion
Gastroenterology
2016English

Clinical Significance of HER2 and EGFR Expression in Colorectal Cancer Patients With Ovarian Metastasis

BMC Clinical Pathology
Forensic MedicinePathologyHistology
2019English

EGFR and HER2 Signaling in Breast Cancer Brain Metastasis

Frontiers in Bioscience - Elite
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2016English

Diet and Biliary Tract Cancer Risk in Shanghai, China

PLoS ONE
Multidisciplinary
2017English

Prognostic and Predictive Values of EGFR Overexpression and EGFR Copy Number Alteration in HER2-positive Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy